About

Mechanical circulatory support has emerged as an important therapy for advanced heart failure. These devices significantly improve survival and quality of life and should be considered in every patient with end-stage heart failure with reduced ejection fraction who has no other life-limiting diseases.

Devices, such as implantable cardioverter-defibrillators (ICDs), and novel pacing technologies, including cardiac resynchronisation therapy (CRT), have helped to complement goal-directed medical therapy and positively impact prognosis in these patients, as demonstrated in multiple high-quality clinical trials.

Articles

Abstract: Right Ventricular Energetic Efficiency Improvement During Left Ventricular Unloading in Post-MI Pigs

Published:

23 March 2021

Citation:

Interventional Cardiology Review 2021;16(Suppl 2):20–1.

Abstract: Impella RP Versus Pharmacological Vasoactive Treatment in Profound Cardiogenic Shock due to Acute Ischemic Occlusion of the Right Coronary Artery

Published:

23 March 2021

Citation:

Interventional Cardiology Review 2021;16(Suppl 2):20.

Abstract: Left Ventricular Unloading Protects Against Both Ischaemic and Reperfusion Injury

Published:

23 March 2021

Citation:

Interventional Cardiology Review 2021;16(Suppl 2):16–7.

ST-segment Elevation MI-Door-to-Unload Trial Updates

Published:

23 March 2021

Citation:

Interventional Cardiology Review 2021;16(Suppl 2):15–6.